Početna › Prekomjerna tjelesna masa › Rhode Island
Kliničke studije za Prekomjerna tjelesna masa u državi Rhode Island
13 studija za Prekomjerna tjelesna masa traži sudionike na lokacijama u državi Rhode Island.
Gradovi u državi Rhode Island
Službeni tekst studije (engleski)
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
- Clinical Res Collaborative, Cumberland
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07720271Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- University Gastroenterology, Providence
U tijeku regrutacijaFaza 3
Od 18 do 70 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06937099Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- University Gastroenterology, Providence
U tijeku regrutacijaFaza 3
Od 18 do 70 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06937086Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Velocity Clinical Research - Providence, East Greenwich
U tijeku regrutacijaFaza 3
Od 45 do 99 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07037433Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, East Greenwich
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 3. ruj 2026. · NCT07284901Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Velocity Clinical Research - Providence, East Greenwich
U tijeku regrutacijaFaza 3
Od 18 do 99 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT07684235Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Velocity Clinical Research - Providence, East Greenwich
U tijeku regrutacijaFaza 3
Od 18 do 99 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT07684144Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
- Women and Infants Hospital of Rhode Island, Providence
U tijeku regrutacija
Od 18 do 45 godina · Žene · Ažurirano 24. lip 2026. · NCT05124808Brain and Behavior Influences on Obesity Development From Infancy Through Childhood
- Rhode Island Hospital, Providence
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 7 do 12 godina · Oba spola · Ažurirano 7. svi 2026. · NCT06861868Microrandomized Trial to Optimize Use of Burden-reducing Self-monitoring Approaches in Behavioral Obesity Treatment
- The Weight Control and Diabetes Research Center of The Miriam Hospital & Brown University, Providence
U tijeku regrutacija
Od 18 do 70 godina · Oba spola · Ažurirano 4. velj 2026. · NCT07228130Pilot Test of Five Weight Neutral Interventions to Improve Health Among Adults of Higher Body Weight
- Weight Control and Diabetes Research Center, Providence
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 23. sij 2026. · NCT07363616Weight Management Intervention in College: A Pilot
- The Miriam Hospital, Providence
U tijeku regrutacija
Od 18 do 29 godina · Oba spola · Ažurirano 1. lis 2025. · NCT06994923Control Systems Engineering for Weight Loss Maintenance
- Miriam Hospital Weight Control and Diabetes Resarch Center, Providence
U tijeku regrutacijaFaza 2
Od 18 do 70 godina · Oba spola · Ažurirano 2. tra 2024. · NCT06244888Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.